ArticleJournal of gastrointestinal oncology2016

Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib.

Akihiro Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.